These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 28360105)

  • 1. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells.
    Manzar GS; Kim EM; Zavazava N
    J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice.
    Raikwar SP; Kim EM; Sivitz WI; Allamargot C; Thedens DR; Zavazava N
    PLoS One; 2015; 10(1):e0116582. PubMed ID: 25629318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
    Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
    Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
    Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
    J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus.
    Amer MG; Embaby AS; Karam RA; Amer MG
    Gene; 2018 May; 654():87-94. PubMed ID: 29452233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic insulin-producing cells differentiated from human embryonic stem cells correct hyperglycemia in SCID/NOD mice, an animal model of diabetes.
    Hua XF; Wang YW; Tang YX; Yu SQ; Jin SH; Meng XM; Li HF; Liu FJ; Sun Q; Wang HY; Li JY
    PLoS One; 2014; 9(7):e102198. PubMed ID: 25009980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient generation of functional pancreatic β-cells from human induced pluripotent stem cells.
    Yabe SG; Fukuda S; Takeda F; Nashiro K; Shimoda M; Okochi H
    J Diabetes; 2017 Feb; 9(2):168-179. PubMed ID: 27038181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of hyperglycemia in diabetic mouse models using induced-pluripotent stem (iPS)-derived pancreatic beta-like cells.
    Alipio Z; Liao W; Roemer EJ; Waner M; Fink LM; Ward DC; Ma Y
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13426-31. PubMed ID: 20616080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Islet-like organoids derived from human pluripotent stem cells efficiently function in the glucose responsiveness in vitro and in vivo.
    Kim Y; Kim H; Ko UH; Oh Y; Lim A; Sohn JW; Shin JH; Kim H; Han YM
    Sci Rep; 2016 Oct; 6():35145. PubMed ID: 27731367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regenerative medicine for diabetes: differentiation of human pluripotent stem cells into functional β-cells in vitro and their proposed journey to clinical translation.
    Bose B; Katikireddy KR; Shenoy PS
    Vitam Horm; 2014; 95():223-48. PubMed ID: 24559920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice.
    Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS
    Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose Tissue From Type 1 Diabetes Mellitus Patients Can Be Used to Generate Insulin-Producing Cells.
    Ikemoto T; Tokuda K; Wada Y; Gao L; Miyazaki K; Yamada S; Saito Y; Imura S; Morine Y; Shimada M
    Pancreas; 2020 Oct; 49(9):1225-1231. PubMed ID: 32898009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-Producing Cells Differentiated from Human Bone Marrow Mesenchymal Stem Cells In Vitro Ameliorate Streptozotocin-Induced Diabetic Hyperglycemia.
    Xin Y; Jiang X; Wang Y; Su X; Sun M; Zhang L; Tan Y; Wintergerst KA; Li Y; Li Y
    PLoS One; 2016; 11(1):e0145838. PubMed ID: 26756576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
    Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
    Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-producing cells from adult human bone marrow mesenchymal stem cells control streptozotocin-induced diabetes in nude mice.
    Gabr MM; Zakaria MM; Refaie AF; Ismail AM; Abou-El-Mahasen MA; Ashamallah SA; Khater SM; El-Halawani SM; Ibrahim RY; Uin GS; Kloc M; Calne RY; Ghoneim MA
    Cell Transplant; 2013; 22(1):133-45. PubMed ID: 22710060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts.
    Motté E; Szepessy E; Suenens K; Stangé G; Bomans M; Jacobs-Tulleneers-Thevissen D; Ling Z; Kroon E; Pipeleers D;
    Am J Physiol Endocrinol Metab; 2014 Nov; 307(9):E838-46. PubMed ID: 25205822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
    El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
    Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human beta-cell precursors mature into functional insulin-producing cells in an immunoisolation device: implications for diabetes cell therapies.
    Lee SH; Hao E; Savinov AY; Geron I; Strongin AY; Itkin-Ansari P
    Transplantation; 2009 Apr; 87(7):983-91. PubMed ID: 19352116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating insulin-producing cells for diabetic therapy: existing strategies and new development.
    Shen J; Cheng Y; Han Q; Mu Y; Han W
    Ageing Res Rev; 2013 Mar; 12(2):469-78. PubMed ID: 23318683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.